-
Drugs Market Size to Skyrocket USD 2895.42 Billion by 2034, reports Healthcare Specialists
26 Sep 2025 13:00 GMT
… drugs. Recently, the FDA has approved novel treatments … Inlexzo (gemcitabine) for bladder cancer. Become a valued … of parenteral medications. Numerous drugs like insulin, … Channel
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Drug Stores
Direct …
-
Natureâs pharmacy: Powerful cancer-fighting foods backed by science
26 Sep 2025 13:48 GMT
… the limitations of conventional treatments and seeking safer, … chemotherapy, radiation and pharmaceutical interventions to treat cancer … side effects of synthetic drugs.
The science behind … active compound that inhibits bladder cancer development. An animal …
-
<![CDATA[Considering Practice-Changing Maintenance Options in Bladder Cancer]]>
26 Sep 2025 01:58 GMT
… Bladder 100 trial (NCT02603432) in patients with advanced bladder cancer.
The JAVELIN … Bladder 100 trial established avelumab ( … rapid change in the frontline treatment of advanced metastatic urothelial …
-
Ongoing clinical trials on BCG/ICI combinations in BCG-naïve NMIBC
26 Sep 2025 02:07 GMT
… mechanisms of resistance that challenge treatment with BCG monotherapy.
Several of … ; NCT03528694) and PATAPSCO (US; NCT05943106) trials.
Although full data from those … high-risk non-muscle invasive bladder cancer patients (ALBAN). ClinicalTrials.gov. Last …
-
FDA Approves Injectable Keytruda for Many Types of Cancer
25 Sep 2025 21:18 GMT
… the Food and Drug Administration (FDA) approved Keytruda Qlex … small-cell lung cancer, bladder cancer, cervical cancer, colorectal … administration may simplify treatment administration, according to … Qlex reached comparable pharmacokinetic exposure levels, …
-
Johnson & Johnson (JNJ) Gains FDA Nod for Subcutaneous Tremfya in Ulcerative Colitis
25 Sep 2025 10:56 GMT
… leader, continues to strengthen its pharmaceuticals and immunology portfolio while delivering … first treatment of its kind, supported by compelling late-stage trial data … portfolio with FDA approval of a new drug delivery system for bladder cancer, offering …
-
Andrea Apolo, MD, outlines the impact of NIAGARA in the MIBC space
26 Sep 2025 14:43 GMT
… the regimen represents a substantial treatment burden, underscoring the need … from adjuvant treatment. Although detailed results are pending, these trials represent … Branch’s Bladder Cancer Section, and director of the Bladder Cancer and Genitourinary …
-
Nature’s Remedies: Foods That Fight Cancer Backed by Scientific Research
26 Sep 2025 13:45 GMT
… or provide alternatives to conventional treatments. While chemotherapy and radiation remain … , an active compound that inhibits bladder cancer development. Additional research in PLoS … on toxic therapies.
Nature’s pharmacy, as Natural Medicine News underscores …
-
I have incurable cancer – if I lived in Scotland, I’d have a drug to extend my life
24 Sep 2025 13:20 GMT
… of applying for certain treatments, including well-established … started testosterone-lowering medication to slow the growth … the recommended treatment plan, Mark sourced the drug privately, … professor of prostate and bladder cancer research at The Institute …
-
FDA grants breakthrough device designation to Virtuoso Surgical Robotic System
23 Sep 2025 17:07 GMT
… en bloc resection for bladder cancer with this level … crucial for guiding subsequent treatment decisions. We are extremely … bladder cancer surgery and patient outcomes."
Virtuoso plans to seek FDA … randomised, multicentre, phase 3 trial. Eur Urol. 2024;86( …